11 results
8-K
EX-10.1
IOBT
IO Biotech Inc
7 Aug 23
IO Biotech, Inc. Announces $75 Million Private Placement Financing
8:31am
No Disqualification Events
No Additional Agreements
Anti-Bribery and Anti-Money Laundering Laws
Cybersecurity
Compliance with Data Privacy Laws
Transactions … Agreements other than as specified in the Transaction Agreements.
3.30 Anti-Bribery and Anti-Money Laundering Laws. Each of the Company, its Subsidiaries
10-K
2021 FY
IOBT
IO Biotech Inc
31 Mar 22
Annual report
5:07pm
of the MA; manufacturing of pharmaceutical products, statutory health insurance, bribery and anti-corruption or with other applicable regulatory … prohibited in the EU. The provision of benefits or advantages to physicians is governed by the national anti-bribery rules of EU Member States
8-K
EX-10.1
IOBT
IO Biotech Inc
6 Dec 21
Entry into a Material Definitive Agreement
9:00am
, entities and individuals; (v) anti-bribery and anti-corruption laws pertaining to interactions with government agents, officials and representatives; (vi … it in obtaining or retaining business for it or the other Party, or in any way with the purpose or effect of public or commercial bribery.
Neither Party
424B4
IOBT
IO Biotech Inc
8 Nov 21
Prospectus supplement with pricing info
5:20pm
and marketing of such products, both before and after grant of the MA; manufacturing of pharmaceutical products, statutory health insurance, bribery … by the national anti-bribery rules of EU Member States. Infringement of these laws could result in substantial fines and imprisonment.
Payments made
S-1/A
EX-10.12
onzzt2t
26 Oct 21
IPO registration (amended)
5:15pm
S-1
e0h b0t5xlekds
15 Oct 21
IPO registration
5:18pm
DRS/A
rv5vo56pj2j370yc 2n
6 Oct 21
Draft registration statement (amended)
12:00am
DRS/A
j9l q0yzjosmq2
9 Aug 21
Draft registration statement (amended)
12:00am
DRS
pjn09g
3 Jun 21
Draft registration statement
12:00am
- Prev
- 1
- Next